'Olumiant Is Already Present In 50 Countries Around The World With More Than 22,000 Patients On It'
Express Pharma|December 01-15,2018

Eli Lilly and Company (India) recently announced the launch of Olumiant (baricitinib), marking the company’s entry into the autoimmune segment in India. Luca Visini, Managing Director, Eli Lilly and Company India, divulges more details about the once-daily oral medication for adult patients with moderate-to-severe active rheumatoid arthritis, it ability to provide relief to those who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs), his company’s plans for this segment, its larger vision for the Indian market and more, in an exclusive tete-a-tete with Lakshmipriya Nair

'Olumiant Is Already Present In 50 Countries Around The World With More Than 22,000 Patients On It'

You have announced the company’s entry into the autoimmune segment in India?

Tell us more about it. It is a very exciting moment, part of that is also luck. This year we’re celebrating 25 years of Lilly’s presence in India. So, it’s a very symbolic time, marking a quartercentury. Today we’re specifically talking about one of those innovations that have characterised Lilly’s presence in India, and we’re talking about the autoimmune space. This, for us, is an important news because it’s the first time that we are entering the autoimmune space for Eli Lilly and Company and we are talking about this at an auspicious time. Just a couple of days before the World Arthritis Day when we’re bringing in the market a therapy for rheumatoid arthritis.

Can you give us an overview on the problem posed by rheumatoid arthritis and the challenges in its management?

Talking about numbers, four to five million people in India are said to be suffering from rheumatoid arthritis. Women are three times more likely to develop rheumatoid arthritis than men and the age during which they are likely to develop rheumatoid arthritis is around 30 to 50 years. It’s a bit early in the lifecycle, and part of the challenge is that around 50 per cent of the people who have been treated with conventional drugs do not achieve remission, they do not feel better, or they feel better in the beginning and then they go back.

It’s not only about the mobility or the stiffnesses; it’s also the pain that comes with it, like holding a pen, getting a cup of coffee or participating in social events. Thus, in rheumatoid arthritis, despite multiple options already in the market, multiple types of therapies, their problems are still huge.

Denne historien er fra December 01-15,2018-utgaven av Express Pharma.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra December 01-15,2018-utgaven av Express Pharma.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA EXPRESS PHARMASe alt
Powerful Process Control with IND500x Weighing Indicators
Express Pharma

Powerful Process Control with IND500x Weighing Indicators

Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.

time-read
1 min  |
November 2024
Ensuring clean room integrity with prime clean reset high-speed doors
Express Pharma

Ensuring clean room integrity with prime clean reset high-speed doors

Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries

time-read
3 mins  |
November 2024
Complete environmental monitoring solution - testo Saveris Pharma
Express Pharma

Complete environmental monitoring solution - testo Saveris Pharma

There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.

time-read
3 mins  |
November 2024
Adaptive Manufacturing:-The new flexibility in medical device assembly
Express Pharma

Adaptive Manufacturing:-The new flexibility in medical device assembly

Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process

time-read
3 mins  |
November 2024
Reshaping pharma safety with active packaging innovations
Express Pharma

Reshaping pharma safety with active packaging innovations

CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India

time-read
1 min  |
November 2024
UNLOCKING GROWTH FRONTIERS
Express Pharma

UNLOCKING GROWTH FRONTIERS

Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem

time-read
9 mins  |
November 2024
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Express Pharma

Optimising cloud provisioning for pharmaceutical compliance and operational excellence

Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik

time-read
3 mins  |
November 2024
Accelerating pharma's sustainability efforts
Express Pharma

Accelerating pharma's sustainability efforts

Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path

time-read
5 mins  |
November 2024
Drug Repurposing: Unlocking access to rare solutions
Express Pharma

Drug Repurposing: Unlocking access to rare solutions

Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases

time-read
8 mins  |
November 2024
Optimising spend, maximising growth
Express Pharma

Optimising spend, maximising growth

Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation

time-read
7 mins  |
November 2024